CoChat

Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression

Leeman-Neill, Rebecca J., Song, Dong, Bizarro, Jonathan, Wacheul, Ludivine, Rothschild, Gerson, Singh, Sameer, Yang, Yang, Sarode, Aditya Y., Gollapalli, Kishore, Wu, Lijing, Zhang, Wanwei, Chen, Yiyun, Lauring, Max C., Whisenant, D. Eric, Bhavsar, Shweta, Lim, Junghyun, Swerdlow, Steven H., Bhagat, Govind, Zhao, Qian, Berchowitz, Luke E., Lafontaine, Denis L. J., Wang, Jiguang, Basu, Uttiya · 2023 · Nature Genetics
Cited by 49

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Whole-genome sequencing of longitudinal tumor pairs representing transformation of follicular lymphoma to high-grade B cell lymphoma with MYC and BCL2 rearrangements (double-hit lymphoma) identified coding and noncoding genomic alterations acquired during lymphoma progression. Many of these transformation-associated alterations recurrently and focally occur at topologically associating domain resident regulatory DNA elements, including H3K4me3 promoter marks located within H3K27ac super-enhancer clusters in B cell non-Hodgkin lymphoma. One region found to undergo recurrent alteration upon transformation overlaps a super-enhancer affecting the expression of the PAX5/ZCCHC7 gene pair. ZCCHC7 encodes a subunit of the Trf4/5-Air1/2-Mtr4 polyadenylation-like complex and demonstrated copy number gain, chromosomal translocation and enhancer retargeting-mediated transcriptional upregulation upon lymphoma transformation. Consequently, lymphoma cells demonstrate nucleolar dysregulation via altered noncoding 5.8S ribosomal RNA processing. We find that a noncoding mutation acquired during lymphoma progression affects noncoding rRNA processing, thereby rewiring protein synthesis leading to oncogenic changes in the lymphoma proteome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-023-01561-1

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 65

  1. Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 40, 413–442 (2022). · DOI · Paper page
  2. Schatz, D. G. & Ji, Y. Recombination centres and the orchestration of V(D)J recombination. Nat. Rev. Immunol. 11, 251–263 (2011). · DOI · Paper page
  3. Alt, F. W., Zhang, Y., Meng, F.-L., Guo, C. & Schwer, B. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 152, 417–429 (2013). · DOI · Paper page
  4. Keim, C., Kazadi, D., Rothschild, G. & Basu, U. Regulation of AID, the B-cell genome mutator. Genes Dev. 27, 1–17 (2013). · DOI · Paper page
  5. Yeap, L.-S. & Meng, F.-L. Cis- and trans-factors affecting AID targeting and mutagenic outcomes in antibody diversification. Adv. Immunol. 141, 51–103 (2019). · DOI
  6. Sun, J., Rothschild, G., Pefanis, E. & Basu, U. Transcriptional stalling in B-lymphocytes: a mechanism for antibody diversification and maintenance of genomic integrity. Transcription 4, 127–135 (2013). · DOI
  7. Robbiani, D. F. & Nussenzweig, M. C. Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase. Annu. Rev. Pathol. 8, 79–103 (2013). · DOI · Paper page
  8. Shaffer, A. L. III, Young, R. M. & Staudt, L. M. Pathogenesis of human B cell lymphomas. Annu. Rev. Immunol. 30, 565–610 (2012). · DOI · Paper page
  9. Feng, Y., Seija, N., Di Noia, J. M. & Martin, A. AID in antibody diversification: there and back again. Trends Immunol. 41, 586–600 (2020). · DOI · Paper page
  10. Meng, F.-L. et al. Convergent transcription at intragenic super-enhancers targets AID-initiated genomic instability. Cell 159, 1538–1548 (2014). · DOI · Paper page
  11. Qian, J. et al. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell 159, 1524–1537 (2014). · DOI · Paper page
  12. Wang, Q. et al. Epigenetic targeting of activation-induced cytidine deaminase. Proc. Natl Acad. Sci. USA 111, 18667–18672 (2014). · DOI
  13. Casellas, R. et al. Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity. Nat. Rev. Immunol. 16, 164–176 (2016). · DOI · Paper page
  14. Panea, R. I. et al. The whole-genome landscape of Burkitt lymphoma subtypes. Blood 134, 1598–1607 (2019). · DOI · Paper page
  15. Horning, S. J. & Rosenberg, S. A. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N. Engl. J. Med. 311, 1471–1475 (1984). · DOI · Paper page
  16. Bastion, Y. et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J. Clin. Oncol. 15, 1587–1594 (1997). · doi:10.1200/jco.1997.15.4.1587
  17. Gallagher, C. J. et al. Follicular lymphoma: prognostic factors for response and survival. J. Clin. Oncol. 4, 1470–1480 (1986). · DOI · Paper page
  18. Davies, A. J. et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br. J. Haematol. 136, 286–293 (2007). · DOI
  19. Gonzalez-Rincon, J. et al. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma. PLoS ONE 14, e0212813 (2019). · DOI
  20. Okosun, J. et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat. Genet. 46, 176–181 (2014). · DOI · Paper page
  21. Pasqualucci, L. et al. Genetics of follicular lymphoma transformation. Cell Rep. 6, 130–140 (2014). · DOI · Paper page
  22. Hilton, L. K. et al. The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood 134, 1528–1532 (2019). · DOI
  23. Kridel, R. et al. Histological transformation and progression in follicular lymphoma: a clonal evolution study. PLoS Med. 13, e1002197 (2016). · DOI · Paper page
  24. Tsukamoto, T. et al. High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif. Sci. Rep. 7, 14039 (2017). · DOI
  25. Boughan, K. M. & Caimi, P. F. Follicular lymphoma: diagnostic and prognostic considerations in initial treatment approach. Curr. Oncol. Rep. 21, 63 (2019). · doi:10.1007/s11912-019-0808-0
  26. Dreyling, M. et al. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 32, 298–308 (2021). · DOI · Paper page
  27. Cleary, M. L. & Sklar, J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl Acad. Sci. USA 82, 7439–7443 (1985). · DOI · Paper page
  28. Liu, D. & Lieber, M. R. The mechanisms of human lymphoid chromosomal translocations and their medical relevance. Crit. Rev. Biochem. Mol. Biol. 57, 227–243 (2022). · DOI
  29. Kämpjärvi, K. et al. Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia. Oncotarget 6, 1884–1888 (2015). · DOI
  30. Morin, R. D. et al. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood 122, 1256–1265 (2013). · DOI · Paper page
  31. Senigl, F. et al. Topologically associated domains delineate susceptibility to somatic hypermutation. Cell Rep. 29, 3902–3915 (2019). · DOI
  32. Bal, E. et al. Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature 607, 808–815 (2022). · DOI · Paper page
  33. Ye, X. et al. Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas. J. Exp. Med. 218, e20200573 (2021). · DOI
  34. Mertz, T. M., Collins, C. D., Dennis, M., Coxon, M. & Roberts, S. A. APOBEC-induced mutagenesis in cancer. Annu. Rev. Genet. 56, 229–252 (2022). · DOI
  35. Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934–947 (2013). · DOI · Paper page
  36. Andrey, G. & Mundlos, S. The three-dimensional genome: regulating gene expression during pluripotency and development. Development 144, 3646–3658 (2017). · DOI · Paper page
  37. Lieberman-Aiden, E. et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326, 289–293 (2009). · DOI · Paper page
  38. Fabbri, G. et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J. Exp. Med. 210, 2273–2288 (2013). · DOI · Paper page
  39. Puente, X. S. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519–524 (2015). · DOI · Paper page
  40. Liu, M. et al. Methodologies for improving HDR efficiency. Front. Genet. 9, 691 (2018). · DOI · Paper page
  41. Laffleur, B. et al. Noncoding RNA processing by DIS3 regulates chromosomal architecture and somatic hypermutation in B cells. Nat. Genet. 53, 230–242 (2021). · DOI · Paper page
  42. Pefanis, E. & Basu, U. RNA exosome regulates AID DNA mutator activity in the B cell genome. Adv. Immunol. 127, 257–308 (2015). · DOI
  43. Rogozin, I. B. & Diaz, M. Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process. J. Immunol. 172, 3382–3384 (2004). · DOI · Paper page
  44. Chong, L. C. et al. High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology. Blood Adv. 2, 2755–2765 (2018). · DOI
  45. Bertrand, P. et al. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas. Leukemia 21, 515–523 (2007). · DOI
  46. Rodriguez-Hernandez, G. et al. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID. Nat. Commun. 10, 5563 (2019). · DOI
  47. Swaminathan, S. et al. Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia. Nat. Immunol. 16, 766–774 (2015). · DOI · Paper page
  48. Kilchert, C., Wittmann, S. & Vasiljeva, L. The regulation and functions of the nuclear RNA exosome complex. Nat. Rev. Mol. Cell Biol. 17, 227–239 (2016). · DOI · Paper page
  49. Puno, M. R., Weick, E. M., Das, M. & Lima, C. D. SnapShot: the RNA exosome. Cell 179, 282–282.e1 (2019). · DOI · Paper page
  50. Allmang, C., Mitchell, P., Petfalski, E. & Tollervey, D. Degradation of ribosomal RNA precursors by the exosome. Nucleic Acids Res. 28, 1684–1691 (2000). · DOI · Paper page
  51. LaCava, J. et al. RNA degradation by the exosome is promoted by a nuclear polyadenylation complex. Cell 121, 713–724 (2005). · DOI · Paper page
  52. Lubas, M. et al. Interaction profiling identifies the human nuclear exosome targeting complex. Mol. Cell 43, 624–637 (2011). · DOI · Paper page
  53. Tafforeau, L. et al. The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of Pre-rRNA processing factors. Mol. Cell 51, 539–551 (2013). · DOI · Paper page
  54. Forester, C. M. et al. Revealing nascent proteomics in signaling pathways and cell differentiation. Proc. Natl Acad. Sci. USA 115, 2353–2358 (2018). · DOI · Paper page
  55. Panda, A. C., Martindale, J. L. & Gorospe, M. Polysome fractionation to analyze mRNA distribution profiles. Bio Protoc. 7, e2126 (2017). · DOI · Paper page
  56. Carlotti, E. et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone. Blood 113, 3553–3557 (2009). · DOI
  57. Marcel, V. et al. p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell 24, 318–330 (2013). · DOI · Paper page
  58. Pelletier, J., Thomas, G. & Volarevic, S. Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat. Rev. Cancer 18, 51–63 (2018). · DOI · Paper page
  59. Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41–44 (2020). · DOI · Paper page
  60. Mumbach, M. R. et al. HiChIRP reveals RNA-associated chromosome conformation. Nat. Methods 16, 489–492 (2019). · DOI · Paper page
  61. Rothschild, G. et al. Noncoding RNA transcription alters chromosomal topology to promote isotype-specific class switch recombination. Sci. Immunol. 5, eaay5864 (2020). · DOI
  62. Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032–2034 (2015). · DOI · Paper page
  63. Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput. Biol. 12, e1004873 (2016). · DOI · Paper page
  64. Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32, 1220–1222 (2016). · doi:10.1093/bioinformatics/btv710
  65. Rao, S. S. P. et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665–1680 (2014). · DOI · Paper page

Cited by

See all 49

Metadata

Authors
Leeman-Neill, R. J., Song, D., Bizarro, J., Wacheul, L., Rothschild, G., Singh, S., Yang, Y., Sarode, A. Y., Gollapalli, K., Wu, L., Zhang, W., Chen, Y., Lauring, M. C., Whisenant, D. E., Bhavsar, S., Lim, J., Swerdlow, S. H., Bhagat, G., Zhao, Q., Berchowitz, L. E., Lafontaine, D. L. J., Wang, J., & Basu, U.
Venue
Nature Genetics
Published
2023-12
Volume
55
Issue
12
Pages
2160-2174
ISSN
  • 1061-4036
  • 1546-1718
Cited by
49
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. https://app.cochat.ai/papers/10.1038/s41588-023-01561-1
The paper
Leeman-Neill, R. J., Song, D., Bizarro, J., Wacheul, L., Rothschild, G., Singh, S., Yang, Y., Sarode, A. Y., Gollapalli, K., Wu, L., Zhang, W., Chen, Y., Lauring, M. C., Whisenant, D. E., Bhavsar, S., Lim, J., Swerdlow, S. H., Bhagat, G., Zhao, Q., . . . Basu, U. (2023). Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. Nature Genetics. https://doi.org/10.1038/s41588-023-01561-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.